Strategies to neutralize RhoA/ROCK pathway after spinal cord injury

Exp Neurol. 2021 Sep:343:113794. doi: 10.1016/j.expneurol.2021.113794. Epub 2021 Jun 22.

Abstract

Regeneration is bungled following CNS injuries, including spinal cord injury (SCI). Inherent decay of permissive conditions restricts the regrowth of the mature CNS after an injury. Hypertrophic scarring, insignificant intrinsic axon-growth activity, and axon-growth inhibitory molecules such as myelin inhibitors and scar inhibitors constitute a significant hindrance to spinal cord repair. Besides these molecules, a combined absence of various mechanisms responsible for axonal regeneration is the main reason behind the dereliction of the adult CNS to regenerate. The neutralization of specific inhibitors/proteins by stymieing antibodies or encouraging enzymatic degradation results in improved axon regeneration. Previous efforts to induce regeneration after SCI have stimulated axonal development in or near lesion sites, but not beyond them. Several pathways are responsible for the axonal growth obstruction after a CNS injury, including SCI. Herein, we summarize the axonal, glial, and intrinsic factor which impedes the regeneration. We have also discussed the methods to stabilize microtubules and through this to maintain the proper cytoskeletal dynamics of growth cone as disorganized microtubules lead to the failure of axonal regeneration. Moreover, we primarily focus on diverse inhibitors of axonal growth and molecular approaches to counteract them and their downstream intracellular signaling through the RhoA/ROCK pathway.

Keywords: CNS injury; CSPG; Microtubules; ROCK; Spinal cord injury.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Humans
  • Myelin-Associated Glycoprotein / metabolism
  • Nerve Regeneration / drug effects
  • Nerve Regeneration / physiology
  • Nogo Proteins / metabolism
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / therapeutic use
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*
  • Spinal Cord Injuries / drug therapy
  • Spinal Cord Injuries / metabolism*
  • rho-Associated Kinases / antagonists & inhibitors
  • rho-Associated Kinases / metabolism*
  • rhoA GTP-Binding Protein / antagonists & inhibitors
  • rhoA GTP-Binding Protein / metabolism*

Substances

  • MAG protein, human
  • Myelin-Associated Glycoprotein
  • Nogo Proteins
  • Protein Kinase Inhibitors
  • RHOA protein, human
  • rho-Associated Kinases
  • rhoA GTP-Binding Protein